Monday, March 12, 2012

Fake Avastin shows very little protects drug supply


Scrutiny of the supply chain has grown since fake versions of Roche's multibillion-dollar cancer drug Avastin turned up at U.S. oncology practices late last year, sparking an international investigation that so far stretches from southern California back to Turkey with a stopover in a Cairo suburb.

Posted via email from Jack's posterous

No comments: